111 Capital »

Halozyme Therapeutics shares owned by 111 Capital

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by 111 Capital from 13F filings

Historical chart of 111 Capital investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by 111 Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by 111 Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $413k 5.6k 73.34
2025-06-30 $689k 13k 52.02